News
Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...
The era of predictive modeling enhanced with machine learning and artificial intelligence (AI) to aid clinical ...
In a significant move, the U.S. Food and Drug Administration granted approval for Kerendia for patients with heart failure ...
Berlin: Bayer has received approval from the U.S. Food and Drug Administration (FDA) for finerenone (Kerendia), a ...
The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.
1h
The Brighterside of News on MSNWeight-loss drug Tirzepatide significantly slows breast cancer growth, study findsKey Takeaways ・The weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer.
Capricor plans to resubmit its application for the approval of deramiocel for DMD after the FDA declined to accept the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results